These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3188387)

  • 21. Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines.
    Maas RA; Komen M; van Diepen M; Oei HL; Claassen IJ
    Vaccine; 2003 Jul; 21(23):3137-42. PubMed ID: 12804840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The quantitative ELISA for inactivated Newcastle antigen: experience report from an OMCL.
    Motitschke A; Jungbäck C
    Dev Biol (Basel); 2012; 134():55-66. PubMed ID: 22888596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan, hydroxypropyltrimethyl ammonium chloride chitosan and sulfated chitosan nanoparticles as adjuvants for inactivated Newcastle disease vaccine.
    Yang Y; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
    Carbohydr Polym; 2020 Feb; 229():115423. PubMed ID: 31826462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on immune efficacy of Newcastle disease chitosan microsphere vaccine].
    Zhai RL; Xu HY; Wang YL; Qin ZM; Jiang SJ
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):692-6. PubMed ID: 17944374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The suitability of various challenge strains of Newcastle disease virus for use in potency tests of live and inactivated vaccine.
    Allan WH; Thornton DH
    J Biol Stand; 1980; 8(2):133-8. PubMed ID: 7410440
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens.
    Folitse R; Halvorson DA; Sivanandan V
    Avian Dis; 1998; 42(1):173-8. PubMed ID: 9533096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of flagellin and an oil-emulsion adjuvant in inactivated Newcastle disease vaccine in stimulation of immunogenic parameters.
    Barkhordari M; Bagheri M; Irian S; Khani MH; Ebrahimi MM; Zahmatkesh A; Shahsavandi S
    Comp Immunol Microbiol Infect Dis; 2021 Apr; 75():101622. PubMed ID: 33607396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of competitive non-protective antigens in a booster killed vaccine on seroconversions to protective antigens of Newcastle disease virus in chickens.
    Barbour EK; Halawi HM; Shaib HA; Jaber LS; Harakeh S
    Vet Ital; 2011; 47(4):461-8. PubMed ID: 22194228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Truncated chicken MDA5 enhances the immune response to inactivated NDV vaccine.
    Han Q; Gao X; Chu Z; Wang X; Eisa Addoma Adam F; Zhang S; Jia Y; Qiu X; Wang X; Yang Z
    Vet Immunol Immunopathol; 2019 Feb; 208():44-52. PubMed ID: 30712791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of binary ethylenimine-inactivated vaccines of Gianyar-1/AK/2014 virulent strain in protecting chickens against Tabanan-1/ARP/2017 virulent Newcastle disease virus isolates.
    Adi AAAM; Astawa INM; Putra IGAA
    Vet World; 2019 Jun; 12(6):758-764. PubMed ID: 31439989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of infectious bursal disease virus by binary ethylenimine and formalin.
    Habib M; Hussain I; Fang WH; Rajput ZI; Yang ZZ; Irshad H
    J Zhejiang Univ Sci B; 2006 Apr; 7(4):320-3. PubMed ID: 16532536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
    Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
    Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Production and trials of inactivated vaccines in oil excipient against Newcastle disease in Ethiopia].
    Thiaucourt F
    Rev Elev Med Vet Pays Trop; 1988; 41(3):229-33. PubMed ID: 3201019
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunisation of fancy chickens against Newcastle disease].
    Freund I; Dzapo V; Vielitz E; Redmann T; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):414-8. PubMed ID: 11721588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Three Types of Inactivation Agents on the Antibody Response and Immune Protection of Inactivated IHNV Vaccine in Rainbow Trout.
    Tang L; Kang H; Duan K; Guo M; Lian G; Wu Y; Li Y; Gao S; Jiang Y; Yin J; Liu M
    Viral Immunol; 2016 Sep; 29(7):430-5. PubMed ID: 27548006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.